Ožbej Zupančič
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems 16
- Drug Solubulity and Delivery Systems 14
- Advancements in Transdermal Drug Delivery 3
- Molecular Medicine top 10%
- Hydrogels: synthesis, properties, applications 3
- Biomaterials top 10%
-
- Protein purification and stability 4
-
- Proteoglycans and glycosaminoglycans research 4
-
- Crystallization and Solubility Studies 3
-
- Ocular Surface and Contact Lens 3
- Co-authors
- Andreas Bernkop‐SchnürchJulia RohrerHung Thanh LamAlexandra PartenhauserGintarė LeonavičiǖtėFlavia LaffleurIrene Pereira de SousaAmrit Paudel
In The Last Decade
Ožbej Zupančič
24 papers receiving 660 citations
Peers
Comparison fields: 5 of 90
- Pharmaceutical Science 471
- Molecular Medicine 49
- Biomaterials 111
- Food Science 65
- Organic Chemistry 91
Countries citing papers authored by Ožbej Zupančič
This map shows the geographic impact of Ožbej Zupančič's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ožbej Zupančič with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ožbej Zupančič more than expected).
Fields of papers citing papers by Ožbej Zupančič
This network shows the impact of papers produced by Ožbej Zupančič. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ožbej Zupančič. The network helps show where Ožbej Zupančič may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ožbej Zupančič, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 41 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 11 | |
| 7 | 2022 | 6 | |
| 8 | 2022 | 14 | |
| 9 | 2017 | 18 | |
| 10 | 2017 | 29 | |
| 11 | 2017 | 10 | |
| 12 | 2017 | 59 | |
| 13 | 2016 | 80 | |
| 14 | 2016 | 31 | |
| 15 | 2016 | 56 | |
| 16 | 2016 | 21 | |
| 17 | 2016 | 66 | |
| 18 | 2016 | 7 | |
| 19 | 2015 | 12 | |
| 20 | 2015 | 67 |
About Ožbej Zupančič
Ožbej Zupančič is a scholar working on Pharmaceutical Science, Molecular Medicine and Pharmacy, having authored 25 papers that have together received 666 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (16 papers), Drug Solubulity and Delivery Systems (14 papers), Protein purification and stability (4 papers), Proteoglycans and glycosaminoglycans research (4 papers), Advancements in Transdermal Drug Delivery (3 papers), Hydrogels: synthesis, properties, applications (3 papers), Crystallization and Solubility Studies (3 papers) and Ocular Surface and Contact Lens (3 papers). The work is most often cited by research in Pharmaceutical Science (471 citations), Molecular Medicine (49 citations) and Biomaterials (111 citations). Ožbej Zupančič has collaborated with scholars based in Austria, Vietnam and Portugal. Frequent co-authors include Andreas Bernkop‐Schnürch, Julia Rohrer, Hung Thanh Lam, Alexandra Partenhauser, Gintarė Leonavičiǖtė, Flavia Laffleur, Irene Pereira de Sousa, Amrit Paudel, Felix Prüfert and Wongsakorn Suchaoin. Their work appears in journals such as Journal of Controlled Release, Carbohydrate Polymers and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.